Hope for a World-class Health System

 2025 marks the year we completed full operational and service integration with Hilaxon, finalising system consolidation, unified customer support, and combined service offerings. Clients and projects formerly managed by RegulatoryEdge now continue under Hilaxon’s integrated services, preserving the same local expertise, high standards and commitment to delivering compliant, timely solutions.

We also continue to stay at the forefront of AI innovation and its expanding applications within the pharmaceutical industry. Image-generation technology has advanced dramatically since 2023, and with thoughtful prompting we have created a new visual for Hilaxon, one that reflects the hope and support we aim to provide to Australian patients facing health challenges. You’d be the judge if this image speaks softly yet powerfully of healing, resilience, and the profound human impact of compassionate care. If it captures not only the clinical but the emotional dimensions of healthcare, where science meets humanity.

Thanks to ARCS Australia and everyone who visited our booth. It was great reconnecting with familiar faces and meeting new ones across our industry. The sessions sparked valuable conversations on topics from regulatory strategy to patient safety and highlighted the importance of sharing experiences, not just data.

At Hilaxon we’re seeing increased demand for regulatory clarity, especially in early stage planning and TGA readiness. Hilaxon brings practical Australian regulatory expertise to help sponsors move from strategy to execution. If you have questions about bringing a therapeutic product to market in Australia, reach out, we’re happy to help.

We'd embarked on an exciting journey of growth and transformation. RegulatoryEdge began evolving into Hilaxon. This transition embraced a fresh identity that aligned with our vision for the future, reflecting our expanded services and capabilities.

While the name and branding took on a new look, the essence and personal touch of our company remained. At Hilaxon, our clients continued to expect the same dedicated, individualised attention and service they'd come to know and appreciate.

Thank you for being part of our journey.

 We’ve been building on decades of tech expertise—starting with programming in BASIC and C++ under founder Enisa—and have continued learning to lead AI applications in Life Sciences, especially Regulatory Affairs and Drug Safety.

In 2023 our team completed the intensive 1:1 course “AI Is My CoPilot” with Laurel Papworth, gaining practical skills with generative AI and large language models. Since then we’ve continued learning and applied those techniques to create tailored solutions for regulatory compliance, pharmacovigilance, medical affairs, and business development.

Partner with Hilaxon to translate AI innovation into practical Life Sciences outcomes: streamline regulatory workflows, boost drug-safety insights, and accelerate growth. Contact us to explore AI-driven projects that improve efficiency and decision-making.

Enisa Savic Hjelmaas is commercially orientated pharmacologist with extensive experience in Scientific Affairs working across a number of various functions, product portfolios and therapeutic areas within the pharmaceutical industry. She is multilingual with international experience.

Key area of expertise include regulatory affairs consulting in area of regulatory development, submissions and commercialisation of products, critical review and analysis of manufacturing, toxicology and clinical data, and negotiation of win-win outcomes with regulatory authorities. Her expertise also extends to medical affairs and pharmacovigilance as well as skills such as project management, and leadership of cross functional initiatives with global scope, ultimately achieving greater business efficiencies and maximising commercial opportunities.  

Enisa's LinkedIn profile is a testament to her industry reputation and expertise, featuring numerous endorsements from colleagues and clients who attest to her skills, knowledge, and professionalism. These endorsements highlight her ability to deliver exceptional results, build strong relationships, and navigate complex regulatory challenges effectively. 

On personal level Enisa is creative, strategic, efficient, and results-oriented problem solver with solid sense of business. She possesses persuasive negotiation skills and enjoys challenging environments, thriving as key member of achievement-oriented team.

Enisa Savic Hjelmaas founded RegulatoryEdge Consultancy in 2017 to meet demand for commercially oriented regulatory affairs consulting services. The firm built a reputation for integrity, professionalism and deep local expertise by attracting and retaining top Australian talent and refusing to outsource work offshore, ensuring confidential, attentive delivery on time and within budget.

RegulatoryEdge became known for its specialist knowledge of the Australian regulatory landscape, a client‑centric approach, and a comprehensive regulatory affairs service offering that supported growth and compliance for Australian and international life‑science companies. Its clients included established firms and start-ups across ethical medicines (small molecules, biologicals and gene therapies), over‑the‑counter medicines, medical devices and cosmetics.